| Product Code: ETC6965468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Oncology NGS Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Oncology NGS Market - Industry Life Cycle |
3.4 Denmark Oncology NGS Market - Porter's Five Forces |
3.5 Denmark Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Denmark Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Denmark Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Denmark Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Denmark Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Denmark Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of cancer in Denmark |
4.2.2 Government initiatives to improve cancer diagnosis and treatment |
4.2.3 Technological advancements in Next-Generation Sequencing (NGS) for oncology applications |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technology and tests |
4.3.2 Limited reimbursement policies for NGS-based oncology tests in Denmark |
5 Denmark Oncology NGS Market Trends |
6 Denmark Oncology NGS Market, By Types |
6.1 Denmark Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Denmark Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Denmark Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Denmark Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Denmark Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Denmark Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Denmark Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Denmark Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Denmark Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Denmark Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Denmark Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Denmark Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Denmark Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Denmark Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Denmark Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Denmark Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Denmark Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Denmark Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Denmark Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Denmark Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Denmark Oncology NGS Market Import-Export Trade Statistics |
7.1 Denmark Oncology NGS Market Export to Major Countries |
7.2 Denmark Oncology NGS Market Imports from Major Countries |
8 Denmark Oncology NGS Market Key Performance Indicators |
8.1 Rate of adoption of NGS technology in oncology diagnostics |
8.2 Number of collaborations between research institutions and healthcare providers for NGS-based oncology research |
8.3 Percentage of oncologists trained in NGS technology and its applications in Denmark |
9 Denmark Oncology NGS Market - Opportunity Assessment |
9.1 Denmark Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Denmark Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Denmark Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Denmark Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Denmark Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Denmark Oncology NGS Market - Competitive Landscape |
10.1 Denmark Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Denmark Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here